Description
British Dispensary FLUX Tesamorelin + Tirzepatide + GHK-Cu is a premium multi-peptide research formulation combining Tesamorelin, Tirzepatide, and GHK-Cu (Copper Tripeptide-1) into a single advanced investigational blend. Developed exclusively for laboratory research, this innovative peptide combination is extensively investigated for its role in endocrine physiology, metabolic regulation, peptide signaling, regenerative biology, and molecular endocrinology through complementary biological mechanisms.
By combining a Growth Hormone-Releasing Hormone (GHRH) analog, a dual GLP-1/GIP receptor agonist, and a copper-binding regenerative peptide, FLUX Tesamorelin + Tirzepatide + GHK-Cu provides researchers with a comprehensive platform for studying growth hormone signaling, glucose metabolism, mitochondrial physiology, extracellular matrix biology, cellular communication, tissue remodeling, and peptide pharmacology.
Each package contains 5 sterile vials, with Tesamorelin 6 mg, Tirzepatide 5 mg, and GHK-Cu 60 mg per vial, providing a total peptide concentration of 71 mg per vial. Manufactured by British Dispensary under stringent pharmaceutical-quality standards, every batch undergoes comprehensive quality testing to ensure exceptional purity, peptide integrity, and dependable laboratory performance.
Key Features
- Premium multi-peptide research formulation
- 5 sterile vials per package
- Tesamorelin – 6 mg per vial
- Tirzepatide – 5 mg per vial
- GHK-Cu (Copper Tripeptide-1) – 60 mg per vial
- Total peptide concentration: 71 mg per vial
- Combines a GHRH analog, dual incretin receptor agonist, and copper-binding peptide
- High-purity laboratory-grade peptide formulation
- Suitable for investigations involving growth hormone physiology, GLP-1 and GIP receptor signaling, metabolic regulation, extracellular matrix biology, regenerative physiology, peptide pharmacology, cellular signaling, and molecular endocrinology
- Manufactured under rigorous pharmaceutical-quality standards
- Intended exclusively for laboratory and scientific research applications
How It Works
FLUX Tesamorelin + Tirzepatide + GHK-Cu combines three investigational peptides with complementary biological mechanisms, allowing researchers to investigate multiple biological pathways within a single laboratory model.
- Tesamorelin – 6 mg is a synthetic Growth Hormone-Releasing Hormone (GHRH) analog that selectively activates the Growth Hormone-Releasing Hormone Receptor (GHRH-R). Researchers investigate its role in growth hormone secretion, IGF-1 regulation, pituitary physiology, and endocrine signaling.
- Tirzepatide – 5 mg is a dual agonist of the Glucagon-Like Peptide-1 (GLP-1) Receptor and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor. It is extensively researched for glucose metabolism, receptor pharmacology, intracellular signaling, energy homeostasis, and metabolic physiology.
- GHK-Cu (Copper Tripeptide-1) – 60 mg is a naturally occurring copper-binding peptide widely investigated for its involvement in extracellular matrix remodeling, cellular communication, tissue physiology, regenerative biology, wound healing mechanisms, and peptide signaling.
Together, these complementary peptides provide researchers with a comprehensive platform for investigating growth hormone physiology, incretin receptor biology, glucose metabolism, tissue remodeling, extracellular matrix regulation, peptide pharmacology, cellular signaling, regenerative science, and molecular endocrinology.
This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.
Contents
Active Ingredients (Per Vial):
- Tesamorelin – 6 mg
- Tirzepatide – 5 mg
- GHK-Cu (Copper Tripeptide-1) – 60 mg
Total Peptide Concentration: 71 mg per Vial
Packaging:
- 5 Sterile Vials
Reviews
There are no reviews yet.